Investigation of the Expression of Inflammatory Markers in Oral Biofilm Samples in Patients with Systemic Scleroderma and the Association with Clinical Periodontal Parameters-A Preliminary Study

Overview

Journal Life (Basel)

Specialty Biology

Date 2021 Nov 27

PMID 34833021

Citations 5

Authors

Mayte Buchbender

Amelie Lugenbuhl

Jakob Fehlhofer

Christian Kirschneck

Jutta Ries

Rainer Lutz

Michael Sticherling

Marco Rainer Kesting

Affiliations

Soon will be listed here.

Abstract

Background: Systemic scleroderma (SSc) has multiple orofacial effects. The aim of this study was to analyze the expression of inflammatory mediators in biofilm samples. It was hypothesized that different expression levels and clinical associations might be drawn.

Methods: A total of 39 biofilm samples from group 1 = SSc and group 2 = healthy control were examined for the expression levels of interleukin (IL)-2,-6, and -10; matrix metalloprotease (MMP)-9; and surface antigens CD90 and CD34 by quantitative real-time PCR and clinical parameters. Relative quantitative (RQ) gene expression was determined using the ∆∆CT method.

Results: The mean bleeding on probing values ( = 0.006), clinical attachment loss (CAL) ( = 0.009), gingival recession ( = 0.020), limited mouth opening ( = 0.001) and cervical tooth defects ( = 0.011) were significantly higher in group 1. RQ expressions of IL-2 and CD34 were significantly lower, IL-6, MMP-9, and CD90 were significantly higher. There was a significant positive correlation of IL-6/MMP-9 and negative correlation of mouth opening/CAL and IL-6/CAL.

Conclusion: Different expression levels of IL-2, IL-6, MMP-9, CD34 and CD90 were detected in biofilm samples from patients with SSc compared to control. An immunological correlation to the clinical parameters of mouth opening and CAL was shown; thus, we conclude that SSc might have an impact on periodontal tissues.

Citing Articles

Orofacial Complications of the Connective Tissue Disease Systemic Sclerosis.

Sharma M, Fadl A, Leask A J Dent Res. 2024; 103(7):689-696.

PMID: 38779873 PMC: 11191658. DOI: 10.1177/00220345241249408.

Expression of Inflammatory Mediators in Biofilm Samples and Clinical Association in Multiple Sclerosis Patients in Remission-A Pilot Study.

Fehlhofer J, Ries J, Nickel F, Rothhammer V, Schwab S, Kesting M Life (Basel). 2024; 14(3).

PMID: 38541692 PMC: 10971373. DOI: 10.3390/life14030367.

Periodontal health status in systemic sclerosis patients: Systematic review and meta-analysis.

Sredojevic S, Colak D, Gaspersic R, Dolijanovic S, Jakovljevic A, Nikolic-Jakoba N PLoS One. 2024; 19(2):e0291078.

PMID: 38306335 PMC: 10836703. DOI: 10.1371/journal.pone.0291078.

Advances in Systemic Sclerosis: From Pathogenetic Pathways toward Novel Therapeutic Targets.

Romano E, Rosa I, Manetti M Life (Basel). 2023; 13(2).

PMID: 36836870 PMC: 9961552. DOI: 10.3390/life13020513.

Orofacial clefts lead to increased pro-inflammatory cytokine levels on neonatal oral mucosa.

Seidel C, Percivalle E, Tschaftari M, Weider M, Strobel K, Willershausen I Front Immunol. 2022; 13:1044249.

PMID: 36466891 PMC: 9714580. DOI: 10.3389/fimmu.2022.1044249.

References

Leung W, Chu C, Mok M, Yeung K, Ng S . Periodontal status of adults with systemic sclerosis: case-control study. J Periodontol. 2011; 82(8):1140-5. DOI: 10.1902/jop.2010.100593. View

Nazari B, Rice L, Stifano G, Barron A, Wang Y, Korndorf T . Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90. Am J Pathol. 2016; 186(10):2650-64. PMC: 5222985. DOI: 10.1016/j.ajpath.2016.06.020. View

Bunaes D, Mustafa M, Mohamed H, Lie S, Leknes K . The effect of smoking on inflammatory and bone remodeling markers in gingival crevicular fluid and subgingival microbiota following periodontal therapy. J Periodontal Res. 2017; 52(4):713-724. DOI: 10.1111/jre.12438. View

Alhendi F, Werth V, Sollecito T, Stoopler E . Systemic sclerosis: Update for oral health care providers. Spec Care Dentist. 2021; 40(5):418-430. DOI: 10.1111/scd.12492. View

Smirani R, Truchetet M, Poursac N, Naveau A, Schaeverbeke T, Devillard R . Impact of systemic sclerosis oral manifestations on patients' health-related quality of life: A systematic review. J Oral Pathol Med. 2018; 47(9):808-815. DOI: 10.1111/jop.12739. View

da Silva K, Coelho L, Do Couto A, de Aguiar M, Tarquinio S, Gomes A . Clinicopathological and immunohistochemical features of the oral lymphoepithelial cyst: A multicenter study. J Oral Pathol Med. 2019; 49(3):219-226. DOI: 10.1111/jop.12978. View

Subbarao K, Nattuthurai G, Sundararajan S, Sujith I, Joseph J, Syedshah Y . Gingival Crevicular Fluid: An Overview. J Pharm Bioallied Sci. 2019; 11(Suppl 2):S135-S139. PMC: 6555362. DOI: 10.4103/JPBS.JPBS_56_19. View

Isola G, Williams R, Lo Gullo A, Ramaglia L, Matarese M, Iorio-Siciliano V . Risk association between scleroderma disease characteristics, periodontitis, and tooth loss. Clin Rheumatol. 2017; 36(12):2733-2741. DOI: 10.1007/s10067-017-3861-9. View

Desallais L, Avouac J, Frechet M, Elhai M, Ratsimandresy R, Montes M . Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis. Arthritis Res Ther. 2014; 16(4):R157. PMC: 4220089. DOI: 10.1186/ar4672. View

10.

Ebersole J, Kirakodu S, Novak M, Stromberg A, Shen S, Orraca L . Cytokine gene expression profiles during initiation, progression and resolution of periodontitis. J Clin Periodontol. 2014; 41(9):853-61. PMC: 4151164. DOI: 10.1111/jcpe.12286. View

11.

Jordan S, Maurer B, Toniolo M, Michel B, Distler O . Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice. Rheumatology (Oxford). 2015; 54(8):1454-8. DOI: 10.1093/rheumatology/keu530. View

12.

Parat K, Radic M, Perkovic D, Lukenda D, Martinovic Kaliterna D . Reduced salivary flow and caries status are correlated with disease activity and severity in patients with diffuse cutaneous systemic sclerosis. J Int Med Res. 2020; 48(10):300060520941375. PMC: 7588767. DOI: 10.1177/0300060520941375. View

13.

Miranda T, Heluy S, Cruz D, da Silva H, Feres M, Figueiredo L . The ratios of pro-inflammatory to anti-inflammatory cytokines in the serum of chronic periodontitis patients with and without type 2 diabetes and/or smoking habit. Clin Oral Investig. 2018; 23(2):641-650. DOI: 10.1007/s00784-018-2471-5. View

14.

Kikuchi K, Kubo M, Hoashi T, Tamaki K . Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis. Clin Exp Dermatol. 2002; 27(4):301-5. DOI: 10.1046/j.1365-2230.2002.01011.x. View

15.

Rubio-Rivas M, Royo C, Simeon C, Corbella X, Fonollosa V . Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum. 2014; 44(2):208-19. DOI: 10.1016/j.semarthrit.2014.05.010. View

16.

Kawamoto D, Amado P, Albuquerque-Souza E, Bueno M, Vale G, Saraiva L . Chemokines and cytokines profile in whole saliva of patients with periodontitis. Cytokine. 2020; 135:155197. DOI: 10.1016/j.cyto.2020.155197. View

17.

Lee J, Park H, Yoon H, Chung J, Cho S . CD34 stromal expression is inversely proportional to smooth muscle actin expression and extent of morphea. J Eur Acad Dermatol Venereol. 2018; 32(12):2208-2216. DOI: 10.1111/jdv.15120. View

18.

Kim H, Kim S, Jeon S, Kim S, Cho H, Choi Y . Diagnostic and Prognostic ability of salivary MMP-9 and S100A8 for periodontitis. J Clin Periodontol. 2020; 47(10):1191-1200. DOI: 10.1111/jcpe.13349. View

19.

Baron M, Hudson M, Dagenais M, MacDonald D, Gyger G, El Sayegh T . Relationship Between Disease Characteristics and Oral Radiologic Findings in Systemic Sclerosis: Results From a Canadian Oral Health Study. Arthritis Care Res (Hoboken). 2015; 68(5):673-80. DOI: 10.1002/acr.22739. View

20.

Pischon N, Hoedke D, Kurth S, Lee P, Dommisch H, Steinbrecher A . Increased Periodontal Attachment Loss in Patients With Systemic Sclerosis. J Periodontol. 2016; 87(7):763-71. DOI: 10.1902/jop.2016.150475. View